Background: Mesenchymal stromal cells (MSCs) have demonstrated therapeutic benefit in preclinical models of necrotizing enterocolitis (NEC), yet clinical translation remains limited by concerns about immune clearance and tumorige... ...

请注册登录后继续浏览